Detalles de la búsqueda
1.
Atezolizumab plus modified docetaxel, cisplatin, and fluorouracil as first-line treatment for advanced anal cancer (SCARCE C17-02 PRODIGE 60): a randomised, non-comparative, phase 2 study.
Lancet Oncol
; 25(4): 518-528, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38547895
2.
Perioperative treatment in resectable gastric cancer with spartalizumab in combination with fluorouracil, leucovorin, oxaliplatin and docetaxel (FLOT): a phase II study (GASPAR).
BMC Cancer
; 22(1): 537, 2022 May 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-35549674
3.
CEA, CA19-9, circulating DNA and circulating tumour cell kinetics in patients treated for metastatic colorectal cancer (mCRC).
Br J Cancer
; 125(5): 725-733, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-34112948
4.
Cognitive rehabilitation program to improve cognition of cancer patients treated with chemotherapy: A 3-arm randomized trial.
Cancer
; 126(24): 5328-5336, 2020 12 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-32996583
5.
Atezolizumab plus modified docetaxel-cisplatin-5-fluorouracil (mDCF) regimen versus mDCF in patients with metastatic or unresectable locally advanced recurrent anal squamous cell carcinoma: a randomized, non-comparative phase II SCARCE GERCOR trial.
BMC Cancer
; 20(1): 352, 2020 Apr 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-32334548
6.
Implantation of tissue expander prior to irradiation in the era of intensity modulated radiotherapy: impact on the management of patients with pelvic digestive cancers.
Int J Colorectal Dis
; 35(3): 559-564, 2020 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-31853620
7.
CA19.9 decrease >15% is a predictor of favourable outcome in patients treated for advanced pancreatic carcinoma: analysis of two independent cohorts.
HPB (Oxford)
; 21(5): 582-588, 2019 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-30466797
8.
Docetaxel, cisplatin, and fluorouracil chemotherapy for metastatic or unresectable locally recurrent anal squamous cell carcinoma (Epitopes-HPV02): a multicentre, single-arm, phase 2 study.
Lancet Oncol
; 19(8): 1094-1106, 2018 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-30042063
9.
Docetaxel, Cisplatin, and 5-fluorouracil (DCF) chemotherapy in the treatment of metastatic or unresectable locally recurrent anal squamous cell carcinoma: a phase II study of French interdisciplinary GERCOR and FFCD groups (Epitopes-HPV02 study).
BMC Cancer
; 17(1): 574, 2017 Aug 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-28841909
10.
Second-line treatment after docetaxel, cisplatin and 5-fluorouracil in metastatic squamous cell carcinomas of the anus. Pooled analysis of prospective Epitopes-HPV01 and Epitopes-HPV02 studies.
Eur J Cancer
; 162: 138-147, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34995900
11.
Pooled analysis of 115 patients from updated data of Epitopes-HPV01 and Epitopes-HPV02 studies in first-line advanced anal squamous cell carcinoma.
Ther Adv Med Oncol
; 12: 1758835920975356, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-33329760
Resultados
1 -
11
de 11
1
Próxima >
>>